Relationships between allergic disease and autoimmunity
https://doi.org/10.18093/0869-0189-2013-0-6-72-78
Abstract
Relationships between allergic disease and autoimmunity.
About the Authors
V. B. GervazievaRussian Federation
V. V. Sveranovskaya
Russian Federation
A. Yu. Konishcheva
Russian Federation
References
1. Sheikh A., Smeeth L., Hubbard R. There is no evidence of an inverse relationship between Th2-mediated atopy and Th1- mediated autoimmune disorders: lack of support for the hygiene hypothesis. J. Allergy Clin. Immunol. 2003; 111 (1): 131–135.
2. Guo J., Rapoport B., McLachlan S.M. Thyroid peroxidase autoantibodies of IgE class in Thyroid autoimmunity. Clin. Immunol. Immunopathol. 1997; 82 (2): 157–162.
3. Воробьева Н.Л., Гервазиева В.Б. Соотношение Th1 и Th2-опосредованного иммунного ответа у детей с вирусными энцефалитами. Russ. J. Immunol. 2001; 6 (4): 383–392.
4. Демкина В.А., Воробьева Н.Л., Шабалина С.В., Гервазиева В.Б. Современные аспекты проблемы вирусных энцефалитов. Сообщение 1. Развитие аутоиммунного демиелинизирующего процесса в ЦНС при вирусных энцефалитах. Инфекц. бол. 2005; 3 (2): 66–70.
5. Potena A., La Corte R., Fabbri L.M. et al. Increased bronchial responsiveness in primary and secondary Sjogren's syndrome. Eur. Respir. J. 1990; 3 (5): 548–553.
6. Hassan W.U., Keaney N.P., Hollan C.D., Kelly C.A. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann. Rheum. Dis. 1994; 53 (8): 511–514.
7. La Corte R., Bajocchi G., Potena A. et al. Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren's syndrome. Ann. Rheum. Dis. 1995; 54 (8): 636–639.
8. Amin K., Ludviksdottir D., Janson C. et al. Bronchial hyperresponsiveness. Inflammation and structural changes in the airways of patients with primary Sjogren's syndrome. Respir. Med. 2001; 95 (11): 904–910.
9. Greaves M.W. Chronic urticaria. J. Allergy Clin. Immunol. 2000; 105 (4): 664–672.
10. Stitt J.M., Dreskin S.C. Urticaria and autoimmunity: where are we now? Curr. Allergy Asthma Rep. 2013; 13 (5): 555–562. DOI 10.1007/s 11882-013-0366-8
11. Konstantinou G.N., Asero R., Ferrer M. et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013; 68 (1): 27–36.
12. Comi A.L., Tedeschi A., Lorini M., Miadonna A. Novel clinical and serological aspects in non-allergic asthma. Respir. Med. 2007; 101 (12): 2526–2533.
13. Tedeschi A., Asero R. Asthma and autoimmunity: a complex but intriguing relation. Expert Rev. Clin. Immunol. 2008; 4 (6): 767–776.
14. Konischeva A.Y., Gervazieva V.B. Autoantibodies and cytokines in bronchial asthma. In: International Proceeding WCA. Monaco: Mediamond, 2008. 163–167.
15. Valenta R., Maurer D., Steiner R. et al. Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 1996; 107: 203–208.
16. Natter S., Seiberler S., Hufnagl P. et al. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J. 1998; 12: 1559–1569.
17. Seiberler S., Natter S., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity. Int. Arch. Allergy Immunol. 1999; 120 (2): 117–125.
18. Altrichter S., Kriehuber E., Moser J. et al. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J. Invest. Dermatol. 2008; 128: 2232–2239.
19. Sugiura K., Muro Y., Nishizava Y. et al. LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J. Invest. Dermatol. 2007; 127 (1): 75–80.
20. Watanabe K., Muro Y., Sugiura K., Tomita Y. IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011; 44 (6): 511–519.
21. Самойликов П.В., Гервазиева В.Б., Кожевников С.А. IgE- и IgG-аутореактивность у детей с атопическим дерматитом. Рос. вестн. перинатол. и педиатр. 2012; 1: 97–102.
22. Bieber T., Novak N. New concepts of atopic dermatitis. From non-IgE-mediated via IgE-mediated to autoimmune inflammation. Allergy Clin. Immunol. Int. J. World Allergy Org. 2005; 17: 26–29.
23. Bar7Sela S., Reshef T., Mekori YA. IgE antithyroid microsomal antibodies in patient with chronic urticaria. J. Allergy Clin. Immunol. 1999; 103: 1216–1217.
24. Sibgatulina N.A., Kuz'mina N.S., Rakhmatullina N.M., Gervazieva V.B. Autoantibodies to thyroid gland antigens in chronic relapsing urticaria. Zh. Mikrobiol. Epidemiol. Immunobiol. 2002; 5: 69–71.
25. Tedeschi A., Lorini M., Asero R. Anti-thyroid peroxidase IgE in patients with chronic urticaria. J. Allergy Clin. Immunol. 2001; 108 (3): 467–468.
26. Altrichter S., Peter H.7J., Pisarevskaja D. et al. IgE mediated autoallergy against thyroid peroxidase – A novel pathomechanism of chronic spontaneous urticaria? PLos One. 2011; 6 (4): e14794.
27. Concha L.B., Chang C.C., Szema A.M. et al. IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy Asthma Proc. 2004; 25 (5): 293–296.
28. Fekri M.S., Shokoochi M., Gozashti M.7H. et al. Association between anti-thyroid peroxidase antibody and asthma in women. Iran J. Allergy Asthma Immunol. 2012; 11 (3): 241–245.
29. Pedulla M., Miraglia Del Giudice M., Fierro V. et al. Atopy as a risk factor for thyroid autoimmunity in children. J. Biol. Regul. Homeost. Agents 2012; 26 (Suppl. 1): 9–14.
30. Pedulla M., Papacciuolo V., Alfano R., Ruocco E. Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis. J. Eur. Acad. Dermatol.Venereol. 2013; doi: 10. 1111/jdv. 12281.
31. Lassalle P., Delneste Y., Gosset P. et al. T and B cell response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur. J. Immunol. 1993; 23 (4): 796–803.
32. Nahm D.7H., Lee Y.E., Yim E.7J. et al. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am. J. Respir. Crit. Care Med. 2002; 165: 1536–1539.
33. Nahm D.7H., Lee Y.E., Shin J.7Y. et al. Identification of α-enolase as an autoantigen associated with severe asthma. J. Allergy Clin. Immunol. 2006; 118: 376–381.
34. Liu M., Subramanian V., Christie Ch. et al. Immune responses to self-antigens in asthma patients: Clinical and immune-pathological implications. Hum. Immunol. 2012; 73 (5): 511–516.
35. Inganas M., Johansson S.G., Bennich H. Anti-IgE antibodies in human serum: occurrence and specificity. Int. Arch. Allergy Appl. Immunol. 1981; 65 (1): 51–61.
36. Lotvall J., Akdis C.A., Bacharier L.B. et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011; 127 (2): 355–360.
37. Wenzel S. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Med. 2012; 18 (5): 716–725.
38. Garn H., Mittermann I., Valenta R., Renz H. Autosensitization as a pathomechanism in asthma. Ann. N.Y. Acad. Sci. 2007; 1107: 417–425.
39. Bunder R., Mittermann I., Herz U. et al. Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma. J. Allergy Clin. Immunol. 2004; 114: 422–428.
40. Seiberler S., Bugajska7Schretter A., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression. Int. Arch. Allergy Immunol. 1999; 120 (2): 108–116.
41. Crameri R., Faith A., Hemmann S. et al. Humoral and cellmediated autoimmunity in allergy to Aspergillus fumigatus. J. Exp. Med. 1996; 184: 265–270.
42. Jayaratnam A., Corrigan C.J., Lee T.H. The continuing enigma of non-atopic asthma. Clin. Exp. Allergy 2005; 35 (7): 835–837.
43. Bachert C., Gevaert P., van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57 (6): 480–487.
44. Штерншис Ю.А., Самойликов П.В., Червинская Т.А., Гервазиева В.Б. Влияние вирусных инфекций на уровень общего IgE при бронхиальной астме и атопическом дерматите. Рос. аллергол. журн. 2004; 3: 32–36.
45. Штерншис Ю.А., Лизогуб Н.В., Кривицкая В.З., Гервазиева В.Б. Острые респираторно-вирусные инфекции и бронхиальная астма. Инфекц. бол. 2006; 4 (3): 18–21.
46. Чучалин А.Г., Оспельникова Т.П., Осипова Г.Л. и др. Роль респираторных инфекций в обострениях бронхиальной астмы. Пульмонология 2007; 5: 14–18.
47. Ten Brinke A., van Dissel J.T., Sterk P.J. et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 2001; 107 (3): 449–454.
48. Раковская И.В., Горина Л.Г., Утюшева М.Г. и др. Инфицированность микоплазмами детей, больных бронхиальной астмой. Журн. микробиол. 2006; 4: 78–81.
49. Atassi M.Z., Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41 (2): 123–132.
50. Braun7Fahrlander C., Riedler J., Herz U. et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 2002; 347: 869–877.
51. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004; 112: 352–363.
52. Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 2007; 119: 1511–1513.
53. Caffarelli C., Cavagni G., Pierdomenico R. et al. Coexistence of IgE-mediated allergy and Type 1 diabetes in childhood. Int. Arch. Allergy Immunol. 2004; 134 (4): 288–294.
54. Tirosh A., Mandel D., Mimouni F.B. et al. Autoimmune diseases in asthma. Ann. Intern. Med. 2006; 144 (12): 877–883.
55. Kero J., Gissler M., Hemminki E., Isolauri E. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, Type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 2001; 108 (5): 781–783.
56. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–787.
57. Roncarolo M.G., Gregori S., Battaglia M. et al. Interleukin10-secreting type 1 regulatory T cells in rodent and humans. Immunol. Rev. 2006; 212: 28–50.
58. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of cell-mediated tissue damage. Nature Med. 2007; 13: 139–145.
59. Alcorn J.F., Crowe Ch.R., Kolls J.K. Th17 cells in Asthma and COPD. Ann. Rev. Physiol. 2010; 72: 495–516.
60. Saito H. Essentials for starting a pediatric clinical study (2): Role of environment and immunity in the development of childhood allergic and immunologic disorders. J. Toxicol. Sci. 2009; 34 (Suppl. 2): S313–S319.
61. Tan C., Gery I. The unique features of Th9 cells and their products. Crit. Rev. Immunol. 2012; 32 (1): 1–10.
Review
For citations:
Gervazieva V.B., Sveranovskaya V.V., Konishcheva A.Yu. Relationships between allergic disease and autoimmunity. PULMONOLOGIYA. 2013;(6):72-78. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-6-72-78